IL-31 / PHARMACEUTICAL COMPOSITION FOR PREVENTION AND/OR TREATMENT OF UREMIC PRURITUS COMPRISING IL-31 ANTAGONIST AS ACTIVE INGREDIENT

비한정적인 일 실시태양에 있어서, IL-31 안타고니스트를 유효 성분으로서 함유하는, 투석 소양증의 예방용 및/또는 치료용 의약 조성물을 제공한다. In a non-limiting embodiment, there is provided a pharmaceutical composition for prevention and/or treatment of uremic pruritus comprising an IL-31 antagonist as an active ingredient....

Full description

Saved in:
Bibliographic Details
Main Authors FUKAZAWA NAOKI, SAITO TOMOHISA, MIHARA RYOSUKE, HIRAHARA TETSUYA, HIROKAWA KEIKO, OKADA FUMIE
Format Patent
LanguageEnglish
Korean
Published 11.04.2023
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:비한정적인 일 실시태양에 있어서, IL-31 안타고니스트를 유효 성분으로서 함유하는, 투석 소양증의 예방용 및/또는 치료용 의약 조성물을 제공한다. In a non-limiting embodiment, there is provided a pharmaceutical composition for prevention and/or treatment of uremic pruritus comprising an IL-31 antagonist as an active ingredient.
Bibliography:Application Number: KR20217018823